» Articles » PMID: 24275386

Suppressed Mitochondrial Biogenesis in Folic Acid-induced Acute Kidney Injury and Early Fibrosis

Overview
Journal Toxicol Lett
Publisher Elsevier
Specialty Toxicology
Date 2013 Nov 27
PMID 24275386
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is a disease with mitochondrial dysfunction and a newly established risk factor for the development of chronic kidney disease (CKD) and fibrosis. We examined mitochondrial homeostasis in the folic acid (FA)-induced AKI model that develops early fibrosis over a rapid time course. Mice given a single dose of FA had elevated serum creatinine (3-fold) and urine glucose (2.2-fold) 1 and 2 d after injection that resolved by 4d. In contrast, peroxisome proliferator gamma coactivator 1α (PGC-1α) and mitochondrial transcription factor A (TFAM), critical transcriptional regulators of mitochondrial biogenesis (MB), were down-regulated ∼80% 1d after FA injection and remained depressed through 14 d. Multiple electron transport chain and ATP synthesis genes were also down-regulated from 1 to 14 d after FA, including NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (NDUFβ8), ATP synthase subunit β (ATPS-β), and cytochrome C oxidase subunit I (COXI). Mitochondrial DNA copy number was reduced ∼50% from 2 to 14 d after FA injection. Protein levels of early fibrosis markers α-smooth muscle actin and transforming growth factor β1 were elevated at 6 and 14 d after FA. Picrosirius red staining and collagen 1A2 (COL1A2) IHC revealed staining for mature collagen deposition at 14 d. We propose that mitochondrial dysfunction induced by AKI is a persistent cellular injury that promotes progression to fibrosis and CKD, and that this model can be used to test mitochondrial therapeutics that limit progression to fibrosis and CKD.

Citing Articles

Integrin-Linked Kinase (ILK) Promotes Mitochondrial Dysfunction by Decreasing CPT1A Expression in a Folic Acid-Based Model of Kidney Disease.

de la Serna-Soto M, Calleros L, Martos-Elvira M, Moreno-Piedra A, Garcia-Villoria S, Griera M Int J Mol Sci. 2025; 26(5).

PMID: 40076489 PMC: 11899702. DOI: 10.3390/ijms26051861.


TEAD1 Prevents Necroptosis and Inflammation in Cisplatin-Induced Acute Kidney Injury Through Maintaining Mitochondrial Function.

Tran M, Jiao B, Du H, Zhou D, Yechoor V, Wang Y Int J Biol Sci. 2025; 21(2):565-578.

PMID: 39781453 PMC: 11705647. DOI: 10.7150/ijbs.104335.


Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways.

Acharya N, Kandel R, Roy P, Warraich I, Singh K Eur J Pharm Sci. 2024; 204:106977.

PMID: 39617304 PMC: 11646179. DOI: 10.1016/j.ejps.2024.106977.


The clinical efficacy of cGMP-specific sildenafil on mitochondrial biogenesis induction and renal damage in cats with acute on chronic kidney disease.

Maden M, Ider M, Or M, Dokuzeylul B, Gulersoy E, Kilickaya M BMC Vet Res. 2024; 20(1):499.

PMID: 39478527 PMC: 11526613. DOI: 10.1186/s12917-024-04345-9.


Central Angiotensin II type 1 receptor deficiency alleviates renal fibrosis by reducing sympathetic nerve discharge in nephrotoxic folic acid-induced chronic kidney disease.

Wan Q, Yang Z, Li L, Wu L PeerJ. 2024; 12:e18166.

PMID: 39346076 PMC: 11439387. DOI: 10.7717/peerj.18166.


References
1.
Kapitsinou P, Jaffe J, Michael M, Swan C, Duffy K, Erickson-Miller C . Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury. Am J Physiol Renal Physiol. 2012; 302(9):F1172-9. PMC: 3362175. DOI: 10.1152/ajprenal.00667.2011. View

2.
Bechtel W, McGoohan S, Zeisberg E, Muller G, Kalbacher H, Salant D . Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010; 16(5):544-50. PMC: 3106179. DOI: 10.1038/nm.2135. View

3.
Choi Y, Chakraborty S, Nguyen V, Nguyen C, Kim B, Shim S . Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol. 2001; 31(12):1491-7. DOI: 10.1053/hupa.2000.20373. View

4.
Fine L, Norman J . Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int. 2008; 74(7):867-72. DOI: 10.1038/ki.2008.350. View

5.
Lan R, Geng H, Polichnowski A, Singha P, Saikumar P, McEwen D . PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol. 2012; 302(9):F1210-23. PMC: 3362177. DOI: 10.1152/ajprenal.00660.2011. View